Luga Technology is committed to the innovation and autonomy of medical isotopes, solving the supply and application scenarios of medical isotopes by innovative means, and helping the research and development of innovative nuclear drugs.

      Luga Technology takes domestic of medical isotope as the breakthrough point, accelerates the key core technology research, and takes the lead in proposing the concept of localization of medical isotopes in China. Luga Technology has been committed to the research and development, production, service and sales of Isotopes , taking "accessible and easy to use, the benefits of nuclear technology to benefit the public" as its mission, and realizing the localization of isotope drugs as its own responsibility.

      In order to achieve the goal of becoming a leader in the field of isotopes in China, we strive to forge ahead.

      At the research and development end, we have achieved breakthroughs in the key core technologies of medical isotope development guided by clinical needs, and have made preliminary results in the production and operation practice of isotope technology and development.

      At the production end, we focus on solving the production and supply problems of medical isotopes, and promote more isotopes from the laboratory to industrialization, scale, and localization.

      On the marketing side, we are striving to achieve stable and independent supply of medical isotopes, accelerate the layout of the market of medical isotope products, continuously follow up the clinical treatment demand of nuclear medicine, and promote the expansion of the market space of nuclear medicine.

Team Introduction:

      The company has a professional team engaged in the R&D, production and operation of medical isotopes for many years.Team members come from Sichuan University, Peking University, research institutes, well-known nuclear pharmaceutical enterprises, etc.They have many years of practical experience in  radioisotope research, drug research and registration, GMP production, safety and environmental protection, market development and other aspects.

      Research and development:we has won the first prize of scientific and Technological progress in Sichuan Province, national high-tech enterprise, provincial specialized and special new Technology Center and other honors, and participated in several provincial and ministerial scientific research projects.

      Drug registration: obtained 2 drug production approval numbers.(Note: Since 2013, China's drug administration has approved only eight radioactive drugs.)

      Design and construction of drug delivery production facilities: familiar with the environment and related qualification evaluation requirements, and obtained more than a dozen kinds of qualifications required for drug delivery production and research and development.In accordance with the GMP standard plant construction, achieved the highest design and construction level of the industry in the year of construction and production, and long-term stable operation;

      Pharmaceutical GMP production: the quality system of large-scale production and timely delivery under the premise of safety and quality control has been established.China only have two teams can achieve nationwide delivery of pharmaceutical products on time outside the same spoke.

      Market experience: established a system and channel to adapt to the distribution of iodine products, the market share of iodine products increases from 0 to 20%.In 2015, the concept of isotope localization was first proposed, and the proportion of localization reached 20% in 2019 (data source: planning documents of eight ministries and commissions).

      Industry work: In 2015, together with the China Academy of Engineering Physics, proposed the localization strategy of medical isotopes and the localization strategy of medical isotopes, and the iodine [I-131] oral solution project became a benchmark demonstration project.On the basis of the above isotope localization project, the China Academy of Engineering Physics promoted the suggestions of academicians and received instructions from national leaders.Promoted the introduction of the documents of the eight ministries and commissions, and the action plan of the eight departments of Sichuan Province.

      Director of industry association, participated in the formulation of industry standards, expert database of Science and Technology Department, participated in the drafting of Shanghai Medical isotopes and Pharmaceutical Industry Planning, and participated in the revision of radioactive drugs management measures.

Chengdu R&D Base

Mianyang Production Base